305 related articles for article (PubMed ID: 9824338)
1. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus.
Marshall RE; Anggiansah A; Manifold DK; Owen WA; Owen WJ
Gut; 1998 Nov; 43(5):603-6. PubMed ID: 9824338
[TBL] [Abstract][Full Text] [Related]
2. Effect of omeprazole on antral duodenogastric reflux in Barrett oesophagus.
Manifold DK; Marshall RE; Anggiansah A; Owen WJ
Scand J Gastroenterol; 2000 Aug; 35(8):796-801. PubMed ID: 10994616
[TBL] [Abstract][Full Text] [Related]
3. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
[TBL] [Abstract][Full Text] [Related]
4. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
Basu KK; Bale R; West KP; de Caestecker JS
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
[TBL] [Abstract][Full Text] [Related]
5. Does the addition of a prokinetic to proton pump inhibitor therapy help reduce duodenogastro-oesophageal reflux in patients with Barrett's oesophagus?
Smythe A; Bird NC; Troy GP; Ackroyd R; Johnson AG
Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):305-12. PubMed ID: 12610326
[TBL] [Abstract][Full Text] [Related]
6. The extent of duodenogastric reflux in gastro-oesophageal reflux disease.
Marshall RE; Anggiansah A; Owen WA; Manifold DK; Owen WJ
Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):5-10. PubMed ID: 11204810
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.
Peters FT; Ganesh S; Kuipers EJ; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
Gut; 1999 Oct; 45(4):489-94. PubMed ID: 10486353
[TBL] [Abstract][Full Text] [Related]
8. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
9. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
Todd JA; Basu KK; de Caestecker JS
Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
[TBL] [Abstract][Full Text] [Related]
10. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus.
Wani S; Sampliner RE; Weston AP; Mathur S; Hall M; Higbee A; Sharma P
Aliment Pharmacol Ther; 2005 Oct; 22(7):627-33. PubMed ID: 16181302
[TBL] [Abstract][Full Text] [Related]
11. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
Lundell L
Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
[TBL] [Abstract][Full Text] [Related]
12. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus.
Vaezi MF; Richter JE
Surgery; 1995 Jun; 117(6):699-704. PubMed ID: 7778033
[TBL] [Abstract][Full Text] [Related]
13. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
Stein HJ; Kauer WK; Feussner H; Siewert JR
J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus.
Caldwell MT; Lawlor P; Byrne PJ; Walsh TN; Hennessy TP
Br J Surg; 1995 May; 82(5):657-60. PubMed ID: 7613943
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor influence on reflux in Barrett's oesophagus.
Smythe A; Troy GP; Ackroyd R; Bird NC
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):881-7. PubMed ID: 18794602
[TBL] [Abstract][Full Text] [Related]
16. Importance of duodenogastric reflux in gastro-oesophageal reflux disease.
Fein M; Maroske J; Fuchs KH
Br J Surg; 2006 Dec; 93(12):1475-82. PubMed ID: 17051600
[TBL] [Abstract][Full Text] [Related]
17. Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 years.
Emken BG; Lundell LR; Wallin L; Myrvold HE; Engström C; Montgomery M; Malm AR; Lind T; Hatlebakk JG;
Scand J Gastroenterol; 2017 Jan; 52(1):11-17. PubMed ID: 27593706
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of pathological duodenogastric reflux and the relationship between duodenogastric and duodenogastrooesophageal reflux in chronic gastrooesophageal reflux disease.
Brillantino A; Monaco L; Schettino M; Torelli F; Izzo G; Cosenza A; Marano L; Di Martino N
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1136-43. PubMed ID: 18946360
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
[TBL] [Abstract][Full Text] [Related]
20. Measuring duodenogastro-oesophageal reflux (DGOR).
de Caestecker JS
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1141-3. PubMed ID: 9471017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
